Pain in the lower abdomen and bloating: What to know
Lower abdominal pain and bloating sometimes occur together. Read on to find out the potential causes of these symptoms and the treatment options available. …read more
Endometriosis: Diagnostic and Treatment Challenges
Noninvasive diagnostic methods and novel treatments are on the horizon for this debilitating and painful condition. Medscape Ob/Gyn …read more
A key area of the brain is smaller in women on the pill
A new study found a dramatic difference in the size of the hypothalamus between women taking the oral contraceptive pill and those not using it. …read more
Three Medical Centers Cancel CBP, ICE Contracts
The three universities cancelled their contracts with US Customs and Border Protection or US Immigration and Customs Enforcement after public pressure. Medscape Medical News …read more
The Lived Experience of Persistent Pain After Breast Cancer
A synthesis of qualitative studies explores the lived experience of persistent pain after breast cancer. Medscape Medical News …read more
Gender Pay Gap, Discrimination Continue in Medicine
Female physicians continue to face pay inequality and harassment by coworkers and patients, leading some to consider early retirement, a new Merritt Hawkins survey finds. Medscape Medical News …read more
Causes of heavy vaginal discharge
Having a certain amount of vaginal discharge is a normal sign of a healthy reproductive system. This article looks at why people may have excessive vaginal discharge and what to do about it. …read more
Premature Menopause: A Warning Signal for CVD Risk
We’re learning more about the effects of early menopause on a woman’s health. Medscape Ob/Gyn …read more
‘Women Don’t Do Well Here’: Physician Job Ad Prompts Anger
A job advertisement for a hospitalist position in Bullhead City, Arizona, sparked outrage on Twitter and has been taken down. Medscape Medical News …read more
FDA OKs New Antibody Drug Conjugate for HER2+ Breast Cancer
Trastuzumab deruxtecan is for the treatment of unresectable or metastatic HER2-positive breast cancer that has received two or more prior anti-HER2-based regimens in the metastatic setting. FDA Approvals …read more